Few people who have undergone nasopharyngeal swabs for coronavirus testing would describe it as a pleasant experience. The procedure involves sticking a long swab up the nose to collect a sample from the back of the nose and throat, which is then analyzed for SARS-CoV-2 RNA by the reverse-transcription polymerase chain reaction (RT-PCR). Now, researchers reporting in ACS Nano have developed a prototype device that non-invasively detected COVID-19 in the exhaled breath of infected patients.
- ‘Best’ hospitals should be required to deliver tobacco treatment
- Suspension of fertility treatments during COVID-19 has mental health impacts
- 40% of O’ahu, Hawai’i beaches could be lost by mid-century
- E. coli bacteria offer path to improving photosynthesis
- Hyperbolic metamaterials exhibit 2T physics